Gainers
- Cingulate Inc (NASDAQ:CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD.
- Akebia Therapeutics Inc (NASDAQ:AKBA) rose 17.5% to $0.87 in pre-market trading. Akebia received CHMP opinion in Europe for vafseo for treatment of symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis.
- Lucira Health Inc (NASDAQ:LHDX) shares rose 17.1% to $0.14 in pre-market trading. Lucira Health shares dropped over 45% on Thursday after the company announced it will pursue a strategic sale of its business through the voluntary Chapter 11 process.
- Atlas Lithium Corp (NASDAQ:ATLX) rose 15.5% to $22.95 in pre-market trading after gaining 60% on Thursday. Atlas Lithium, last month, signed a MOU with Mitsui & Co. with respect to Mitsui's potential interest in acquiring the right to purchase Atlas Lithium's future lithium concentrate production.
- AIM ImmunoTech Inc (NYSE:AIM) shares rose 15.2% to $0.57 in pre-market trading. AIM ImmunoTech, last month, entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca.
- Beyond Meat Inc (NASDAQ:BYND) rose 14% to $19.54 in pre-market trading after the company reported better-than-expected financial results for its fourth quarter on Thursday.
- Amesite Inc (NASDAQ:AMST) rose 11.6% to $2.70 in pre-market trading. Amesite recently announced a 1-for-12 reverse stock split.
- Troika Media Group Inc (NASDAQ:TRKA) rose 11.5% to $0.29 in pre-market trading. Troika Media Group retained Jefferies LLC to help explore strategic alternatives.
- Farfetch Ltd (NYSE:FTCH) rose 8.9% to $5.39 in pre-market trading after the company reported better-than-expected Q4 results. The company also said that its CFO will step down by end of 2023.
- Block Inc (NYSE:SQ) shares rose 7.8% to $80.00 in pre-market trading as the company posted upbeat sales results for its fourth quarter.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Nektar Therapeutics (NASDAQ:NKTR) shares fell 39.2% to $1.80 in pre-market trading after the company reported Phase 2 topline data for rezpegaldesleukin in patients with systemic lupus erythematosus.
- Ocean Biomedical Inc (NASDAQ:OCEA) fell 17.1% to $8.95 in pre-market trading. Ocean Biomedical shares jumped around 125% on Thursday after the company issued a press release celebrating the discovery of bispecific antibodies and immune checkpoint inibitors that kill glioblastoma cells and melanoma cells and block the metastasis of malignant melanoma cells to the lung by over 90%.
- Bigcommerce Holdings Inc (NASDAQ:BIGC) shares dropped 16.6% to $9.45 in pre-market trading after the company reported downbeat Q4 sales and issued weak sales forecast.
- ContextLogic Inc (NASDAQ:WISH) fell 12.5% to $0.62 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results.
- Hexo Corp (NASDAQ:HEXO) fell 7.8% to $1.52 in pre-market trading after declining 3% on Thursday.
- Ambrx Biopharma Inc - ADR (NYSE:AMAM) fell 7.5% to $6.04 in pre-market after jumping 45% on Thursday. Ambrx Biopharma recently announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
- RedHill Biopharma Ltd (NASDAQ:RDHL) fell 6.9% to $0.20 in pre-market trading.
- Vascular Biogenics Ltd (NASDAQ:VBLT) fell 6.8% to $0.16 in pre-market trading. Vascular Biogenics shares jumped around 30% on Thursday after the company and Notable Labs announced a definitive merger agreement.
- Opendoor Technologies Inc (NASDAQ:OPEN) shares fell 5% to $1.73 in pre-market trading after reporting Q4 results.
- Expion360 Inc (NASDAQ:XPON) fell 4.1% to $3.77 in pre-market trading after surging 42% on Thursday.
Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.